{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:04:59Z","timestamp":1767204299573,"version":"build-2238731810"},"reference-count":49,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"DOI":"10.3389\/fmolb.2016.00067","type":"journal-article","created":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T08:28:32Z","timestamp":1476347312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Designer Leptin Receptor Antagonist Allo-aca Inhibits VEGF Effects in Ophthalmic Neoangiogenesis Models"],"prefix":"10.3389","volume":"3","author":[{"given":"Roberta","family":"Coroniti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafal","family":"Fario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier J.","family":"Nuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Otvos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Scolaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Surmacz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,10,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"648239","DOI":"10.1155\/2015\/648239","article-title":"Differential effects of leptin and adiponectin in endothelial angiogenesis","volume":"2015","author":"Adya","year":"2015","journal-title":"J. Diabetes Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cyto.2008.03.009","article-title":"Human leptin induces angiogenesis in vivo","volume":"42","author":"Anagnostoulis","year":"2008","journal-title":"Cytokine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-08-0642","article-title":"Insulin-dependent leptin expression in breast cancer cells","volume":"68","author":"Bartella","year":"2008","journal-title":"Cancer Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vph.2006.06.014","article-title":"Leptin inhibits cell growth of human vascular smooth muscle cells","volume":"46","author":"Bohlen","year":"2007","journal-title":"Vascul. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1161\/01.RES.83.10.1059","article-title":"Leptin, the product of Ob gene, promotes angiogenesis","volume":"83","author":"Bouloumi\u00e9","year":"1998","journal-title":"Circ. Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1073\/pnas.101564798","article-title":"Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF","volume":"98","author":"Cao","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B7","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/sj.onc.1210660","article-title":"Mechanism of leptin expression in breast cancer cells: role of hypoxia-inducible factor-1\u03b1","volume":"27","author":"Cascio","year":"2008","journal-title":"Oncogene"},{"key":"B8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/dom.12008","article-title":"KH902 suppresses high glucose-induced migration and sprouting of human retinal endothelial cells by blocking VEGF and PIGF","volume":"15","author":"Chen","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/1471-2407-11-303","article-title":"Glioblastoma-derived leptin induces tube formation and growth of endothelial cells: comparison with VEGF effects","volume":"11","author":"Ferla","year":"2011","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","article-title":"Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration","volume":"26","author":"Ferrara","year":"2006","journal-title":"Retina"},{"key":"B12","first-page":"3576","article-title":"Elevation of vitreous leptin in diabetic retinopathy and retinal detachment","volume":"41","author":"Gariano","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e18823","DOI":"10.1371\/journal.pone.0018823","article-title":"Vascular endothelial growth factor receptor-2 couples cyclo-oxygenase-2 with pro-angiogenic actions of leptin on human endothelial cells","volume":"6","author":"Garonna","year":"2011","journal-title":"PLoS ONE"},{"key":"B14","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jnutbio.2009.05.004","article-title":"Involvement of serum vascular endothelial growth factor family members in the development of obesity in mice and humans","volume":"21","author":"G\u00f3mez-Ambrosi","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.cellsig.2010.05.003","article-title":"Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NF\u03baB\/HIF-1\u03b1 activation","volume":"22","author":"Gonzalez-Perez","year":"2010","journal-title":"Cell. Signal."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1073\/pnas.172398299","article-title":"VEGF-Trap: a VEGF blocker with potent antitumor effects","volume":"99","author":"Holash","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B17","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1167\/iovs.15-16793","article-title":"Angiogenic and inflammatory vitreous biomarkers associated with increasing levels of retinal ischemia","volume":"56","author":"Kovacs","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/carcin\/bgp292","article-title":"Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling","volume":"31","author":"Lu","year":"2010","journal-title":"Carcinogenesis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/sj.eye.6702011","article-title":"Vitreous leptin levels in retinal disease","volume":"20","author":"Maberley","year":"2006","journal-title":"Eye (Lond)."},{"key":"B20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s00125-016-3898-3","article-title":"The role of leptin in diabetes: metabolic effects","volume":"59","author":"Meek","year":"2016","journal-title":"Diabetologia"},{"key":"B21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.5.2.9","article-title":"VEGF: from discovery to therapy: the champalimaud award lecture","volume":"5","author":"Miller","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmed.2015.12.001","article-title":"Leptin regulation of immune responses","volume":"22","author":"Naylor","year":"2016","journal-title":"Trends Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.mce.2013.03.025","article-title":"Leptin-cytokine crosstalk in breast cancer","volume":"382","author":"Newman","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"B25","first-page":"141","article-title":"Leptin stimulates rat aortic smooth muscle cell proliferation and migration","volume":"47","author":"Oda","year":"2001","journal-title":"Kobe J. Med. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.ejca.2011.01.018","article-title":"Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer","volume":"47","author":"Otvos","year":"2011a","journal-title":"Eur J Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.peptides.2011.06.015","article-title":"Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis","volume":"32","author":"Otvos","year":"2011b","journal-title":"Peptides"},{"key":"B28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/emm.2001.17","article-title":"Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro","volume":"33","author":"Park","year":"2001","journal-title":"Exp. Mol. Med."},{"key":"B29","first-page":"1062","article-title":"Leptin mediates hyperglycemia-induced angiogenic effects in retinal endothelial cells","volume":"2","author":"Parrino","year":"2014","journal-title":"J. Endocrinol. Diabetes Obes."},{"key":"B30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.2174\/157339910793360815","article-title":"Angiogenic growth factors and their inhibitors in diabetic retinopathy","volume":"6","author":"Praidou","year":"2010","journal-title":"Curr. Diabetes Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"105489","DOI":"10.1155\/2010\/105489","article-title":"Leptin inhibits the proliferation of vascular smooth muscle cells induced by angiotensin II through nitric oxide-dependent mechanisms","volume":"2010","author":"Rodr\u00edguez","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"B32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1586\/eem.10.61","article-title":"Leptin-based therapeutics","volume":"5","author":"Scolaro","year":"2010","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e76437","DOI":"10.1371\/journal.pone.0076437","article-title":"Exploring leptin antagonism in ophthalmic cell models","volume":"8","author":"Scolaro","year":"2013","journal-title":"PLoS ONE"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e53502","DOI":"10.3791\/53502","article-title":"A mouse model for laser-induced choroidal neovascularization","volume":"106","author":"Shah","year":"2015","journal-title":"J. Vis. Exp."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1126\/science.281.5383.1683","article-title":"Biological action of leptin as an angiogenic factor","volume":"281","author":"Sierra-Honigmann","year":"1998","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.mayocp.2011.10.001","article-title":"The expanding role of vascular endothelial growth factor inhibitors in ophthalmology","volume":"87","author":"Stewart","year":"2012","journal-title":"Mayo. Clin. Proc."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.2337\/diabetes.53.9.2443","article-title":"Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells","volume":"53","author":"Suganami","year":"2004","journal-title":"Diabetes"},{"key":"B38","first-page":"5008","article-title":"Effect of tetrandrine on the expression of leptin (LP) and vascular endothelial growth factor (VEGF) in corneal neovascularization of rats","volume":"6","author":"Sun","year":"2011","journal-title":"Sci. Res. Essays"},{"key":"B39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11010-010-0495-5","article-title":"Intermittent high glucose enhances cell proliferation and VEGF expression in retinal endothelial cells: the role of mitochondrial reactive oxygen species","volume":"343","author":"Sun","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10911-013-9302-8","article-title":"Leptin and adiponectin: emerging therapeutic targets in breast cancer","volume":"18","author":"Surmacz","year":"2013","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1515\/hmbci-2015-0007","article-title":"Molecular targeting of obesity pathways in cancer","volume":"22","author":"Surmacz","year":"2015","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"B42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrcardio.2009.224","article-title":"Cardiovascular effects of leptin","volume":"7","author":"Sweeney","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00109-010-0709-z","article-title":"Emerging therapeutic approaches in the management of retinal angiogenesis and edema","volume":"89","author":"Truong","year":"2011","journal-title":"J. Mol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.metabol.2014.10.021","article-title":"The role of leptin in regulating bone metabolism","volume":"64","author":"Upadhyay","year":"2015","journal-title":"Metab. Clin. Exp."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.2174\/1381612821666150225120314","article-title":"Anti-VEGF drugs in eye diseases: local therapy with potential systemic effects","volume":"21","author":"van der Giet","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"B47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11892-012-0289-0","article-title":"Novel targets against retinal angiogenesis in diabetic retinopathy","volume":"12","author":"Wang","year":"2012","journal-title":"Curr. Diab. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1530\/eje.0.1430293","article-title":"Human leptin: from an adipocyte hormone to an endocrine mediator","volume":"143","author":"Wauters","year":"2000","journal-title":"Eur. J. Endocrinol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"209538","DOI":"10.1155\/2012\/209538","article-title":"Vascular complications and diabetes: current therapies and future challenges","volume":"2012","author":"Willard","year":"2012","journal-title":"J. Ophthalmol."}],"updated-by":[{"DOI":"10.3389\/fmolb.2016.00075","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T00:00:00Z","timestamp":1479427200000}}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmolb.2016.00067\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T08:28:33Z","timestamp":1476347313000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmolb.2016.00067\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,13]]},"references-count":49,"URL":"https:\/\/doi.org\/10.3389\/fmolb.2016.00067","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,13]]}}}